BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 14963200)

  • 21. The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational study.
    Flendrie M; Creemers MC; Welsing PM; van Riel PL
    Rheumatology (Oxford); 2005 Apr; 44(4):472-8. PubMed ID: 15598707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial.
    Kremer J; Genovese M; Cannon GW; Caldwell J; Cush J; Furst DE; Luggen M; Keystone E; Bathon J; Kavanaugh A; Ruderman E; Coleman P; Curtis D; Kopp E; Kantor S; Weisman M; Waltuck J; Lindsley HB; Markenson J; Crawford B; Fernando I; Simpson K; Strand V
    J Rheumatol; 2004 Aug; 31(8):1521-31. PubMed ID: 15290730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial.
    Stone JH; Holbrook JT; Marriott MA; Tibbs AK; Sejismundo LP; Min YI; Specks U; Merkel PA; Spiera R; Davis JC; St Clair EW; McCune WJ; Ytterberg SR; Allen NB; Hoffman GS;
    Arthritis Rheum; 2006 May; 54(5):1608-18. PubMed ID: 16646004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy of leflunomide monotherapy in rheumatoid arthritis: towards the goals of disease modifying antirheumatic drug therapy.
    Smolen JS; Emery P; Kalden JR; Van Riel PL; Dougados M; Strand CV; Breedveld FC
    J Rheumatol Suppl; 2004 Jun; 71():13-20. PubMed ID: 15170903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved outcome in 445 patients with Wegener's granulomatosis in a German vasculitis center over four decades.
    Holle JU; Gross WL; Latza U; Nölle B; Ambrosch P; Heller M; Fertmann R; Reinhold-Keller E
    Arthritis Rheum; 2011 Jan; 63(1):257-66. PubMed ID: 20862686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations.
    Holle JU; Dubrau C; Herlyn K; Heller M; Ambrosch P; Noelle B; Reinhold-Keller E; Gross WL
    Ann Rheum Dis; 2012 Mar; 71(3):327-33. PubMed ID: 22021864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis.
    Solans-Laqué R; Bosch-Gil J; Canela M; Lorente J; Pallisa E; Vilardell-Tarrés M
    Lupus; 2008 Sep; 17(9):832-6. PubMed ID: 18755865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of leflunomide and predisposing factors for treatment response in patients with active rheumatoid arthritis: RELIEF 6-month data.
    Dougados M; Emery P; Lemmel EM; de la Serna R; Zerbini CA; Brin S; van Riel P
    J Rheumatol; 2003 Dec; 30(12):2572-9. PubMed ID: 14719196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).
    Seo P; Min YI; Holbrook JT; Hoffman GS; Merkel PA; Spiera R; Davis JC; Ytterberg SR; St Clair EW; McCune WJ; Specks U; Allen NB; Luqmani RA; Stone JH;
    Arthritis Rheum; 2005 Jul; 52(7):2168-78. PubMed ID: 15986348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Azathioprine for long-term maintenance of remission in autoimmune hepatitis.
    Johnson PJ; McFarlane IG; Williams R
    N Engl J Med; 1995 Oct; 333(15):958-63. PubMed ID: 7666914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis.
    van Denderen JC; van der Paardt M; Nurmohamed MT; de Ryck YM; Dijkmans BA; van der Horst-Bruinsma IE
    Ann Rheum Dis; 2005 Dec; 64(12):1761-4. PubMed ID: 15901634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experience with rituximab treatment (monoclonal antibodies to B-lymphocyte CD20 receptors) of Wegener's granulomatosis patients with renal impairment].
    Novikov PI; Krivosheev OG; Semenkova EN
    Ter Arkh; 2011; 83(11):70-6. PubMed ID: 22312891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial.
    Stone JH;
    Arthritis Rheum; 2003 Aug; 48(8):2299-309. PubMed ID: 12905485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjunctive anakinra in patients with active rheumatoid arthritis despite methotrexate, or leflunomide, or cyclosporin-A monotherapy: a 48-week, comparative, prospective study.
    Karanikolas G; Charalambopoulos D; Vaiopoulos G; Andrianakos A; Rapti A; Karras D; Kaskani E; Sfikakis PP
    Rheumatology (Oxford); 2008 Sep; 47(9):1384-8. PubMed ID: 18603660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients.
    Faurschou M; Sorensen IJ; Mellemkjaer L; Loft AG; Thomsen BS; Tvede N; Baslund B
    J Rheumatol; 2008 Jan; 35(1):100-5. PubMed ID: 17937462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leflunomide versus methotrexate in Wegener's granulomatosis.
    Jayne D
    Rheumatology (Oxford); 2007 Jul; 46(7):1047-8. PubMed ID: 17409129
    [No Abstract]   [Full Text] [Related]  

  • 37. Update on the treatment of Wegener's granulomatosis.
    Esper GJ; Johnson JS
    Bull Rheum Dis; 1999; 48(11):1-4. PubMed ID: 10721552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trial.
    van Tuyl LH; Lems WF; Voskuyl AE; Kerstens PJ; Garnero P; Dijkmans BA; Boers M
    Ann Rheum Dis; 2008 Nov; 67(11):1574-7. PubMed ID: 18625629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can sulfasalazine therapy induce or exacerbate Wegener's granulomatosis?
    Denissen NH; Peters JG; Masereeuw R; Barrera P
    Scand J Rheumatol; 2008; 37(1):72-4. PubMed ID: 18189198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.